Kbota- also always looking at new drugs and have some hopefullness for we patients, but also challenge what is going on out there in the name of drugs for us. Hope this one pans out and is worthy, hopefully reasonable in future costs.
Looks like it has estrogens in it (LOL), killer, blood clots, dvt's almost certain. (LOL). I think it is going to be found as a newly re-engineered cross-over drug with DES or emcyt (estrogenics) within the pill and 'IF' approved a wonderful new price tag, atleast as high as Lupron which they compare it to(my guess), hey it is considered reasonable to charge $10,000 a year or more for controlling PCa and some much higher than that.
There are currently only so many pathways known to effect PCa, so alot of these new drugs are actually working on the same pathways and many are ineffect re-engineering of already found effective drug or compounds, maybe tweated a bit and maybe better (perhaps). Certainly more profittable than the older 'junk'. (LOL) Example: Abiraterone targets the same enyme as Ketoconazole (CYP17), maybe it is better than Keto. The price differential is astounding. Here is a link to a photo from the AUA meeting recently held (hope is it ok to post this)
http://preview.tinyurl.com/3tw5qat (click on 'proceed to site')
(big promotional event) (reference cost comparison: Keto as low as $130/mo. vs. Abi./Zytiga at $5,000/ mo. (these are pills, both use prednisone to counter act some things).
Post Edited (zufus) : 6/20/2011 7:26:36 AM (GMT-6)